KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Other Accumulated Expenses (2019 - 2023)

Cvs Health (CVS) has disclosed Other Accumulated Expenses for 5 consecutive years, with $12.6 billion as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other Accumulated Expenses rose 23.88% year-over-year to $12.6 billion, compared with a TTM value of $12.6 billion through Sep 2023, up 23.88%, and an annual FY2022 reading of $10.1 billion, up 16.87% over the prior year.
  • Other Accumulated Expenses was $12.6 billion for Q3 2023 at Cvs Health, up from $12.0 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $12.6 billion in Q3 2023 and bottomed at $6.9 billion in Q4 2019.
  • Average Other Accumulated Expenses over 5 years is $9.9 billion, with a median of $10.1 billion recorded in 2022.
  • Peak annual rise in Other Accumulated Expenses hit 23.88% in 2023, while the deepest fall reached 7.82% in 2023.
  • Year by year, Other Accumulated Expenses stood at $6.9 billion in 2019, then grew by 15.37% to $7.9 billion in 2020, then grew by 9.35% to $8.7 billion in 2021, then increased by 16.87% to $10.1 billion in 2022, then grew by 23.74% to $12.6 billion in 2023.
  • Business Quant data shows Other Accumulated Expenses for CVS at $12.6 billion in Q3 2023, $12.0 billion in Q2 2023, and $10.9 billion in Q1 2023.